Cart mincart
home
Search Results

Chikungunya Fever

by Instructor: Brittani Zurek, PharmD

$23.00

i 1.25 Hours

Course Overview

CHIKV was only identified in a handful of cases prior to 2014. The disease is still relatively uncommon compared to other arboviral diseases and primarily affects travelers. Most pharmacists have never seen a clinical case of CHIKV infection. Since this is a new disease in the U.S., experts are still learning about CHIKV infection and trying to determine the most effective management strategies. New guidelines and studies discussing effective management and identification of symptoms of CHIKV infection have recently been released based on data from the La Réunion epidemic. It is important for pharmacists to be updated on the most recent recommendations for the identification, treatment, and prevention of CHIKV infection. Since this is a disease that is still new in the U.S., pharmacists may be unfamiliar with CHIKV, symptoms of infection, proper management, and prevention strategies. This module will provide an overview of CHIKV, transmission methods, symptoms, ways to confirm CHIKV infection, treatment, and prevention strategies.

About the Course Author

Brittani Zurek, PharmD, is a pharmacist and medical writer who graduated from the University at Buffalo School of Pharmacy. Brittani Zurek, PharmD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.

Get started now and your first course is free!

Become a member today and enjoy instant savings on all courses
GET CE-PRO

Accreditation Information

Certificates provided by accrediting body (15 Match)

  • American Nurses Credentialing Center

    1.25HOURS


    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Nurses will receive 1.25 Nursing Contact Hours after successfully completing this course.

  • California Board of Registered Nursing

    1.25HOURS

    Provider approved by the California Board of Registered Nursing, CEP# 658025 Nurses will receive 1.25 contact hours for participating in this course.

  • District of Columbia Board of Nursing

    1.20HOURS


    District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).

    Nurses will receive 1.2 contact hours for participating in this course.

  • Florida Board of Nursing

    1.00HOURS


    Florida Board of Nursing (CEBroker Provider #50-290)

    Nurses will receive 1.0 contact hours for participating in this course.

  • Georgia Board of Nursing

    1.25HOURS


    Georgia Board of Nursing (CEBroker Provider #50-290)

    Nurses will receive 1.25 contact hours for participating in this course.

  • South Carolina Board of Nursing

    1.25HOURS


    South Carolina Board of Nursing (CEBroker Provider #50-290)

    Nurses will receive 1.25 contact hours for participating in this course.

  • Florida Board of Clinical Laboratory Personnel

    1.00HOURS


    Florida Board of Clinical Laboratory Personnel (CEBroker Provider #: 50-290)

    Clinical Laboratory Personnel will receive 1.0 contact hours for participating in this course.

  • American Society for Clinical Laboratory Science

    1.25HOURS


    Relias LLC is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.

  • West Virginia Board of Registered Nursing

    1.25HOURS


    West Virginia Board of Registered Nursing (CEBroker Provider #50-290)

    Nurses will receive 1.25 contact hours for participating in this course.

  • Accreditation Council for Pharmacy Education

    1.25HOURS


    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Type Activity: Knowledge Target Audience Designation: P ACPE Universal Activity Number: JA4008266-0000-21-173-H01-P

  • New Mexico Board of Nursing

    1.25HOURS


    New Mexico Board of Nursing (CEBroker Provider #50-290)

    Nurses will receive 1.25 contact hours for participating in this course.

  • Arkansas State Board of Nursing

    1.25HOURS


    Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).

    Nurses will receive 1.25 contact hours for participating in this course.

  • Tennessee Medical Laboratory Board

    1.00HOURS


    Tennessee Medical Laboratory Board (CEBroker Provider #50-290)

  • Florida Board of Pharmacy

    1.25HOURS


    Florida Board of Pharmacy (CEBroker Provider #50-290)

    This module is approved for 1.25 contact hours.

  • Louisiana Board of Medical Examiners- Clinical Laboratory Personnel

    1.25HOURS


    Louisiana Board of Medical Examiners - Clinical Laboratory Personnel (CEBroker Provider #50-290)



Course Details

  • Course Code:

    REL-ACU-0-PHARMCF

  • Hours:

    1.25

  • Type:

    Online Course

  • Release Date:

    2020-04-01

  • Expiration Date:

    2022-05-07

  • Learning Objectives:

    Describe differentiating factors between CHIKV and dengue virus infection; Identify symptoms of CHIKV infection; List prevention methods to limit CHIKV transmission; Review management options for symptoms of CHIKV infection; Review the epidemiology of Chikungunya virus (CHIKV) and its methods of transmission

  • Target Audience:

    The target audience for this course is: Entry level Clinical Laboratory Personnel; Nurses; Pharmacists; in the following settings: Acute Care Facility.

  • Course Delivery Method and Format:

    Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
    Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
    If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
    All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
    Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
    All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
    To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.

  • Accommodations:

    If you require special accommodations to complete this module, please contact Relias Customer Support here.

  • Disclosures:

    Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.